Kansas Hospital Association

2nd Annual Kansas Opioid Conference 

Thursday, November 15, 2018
Capitol Plaza Hotel and Convention Center
1717 SW Topeka Blvd., Topeka, KS 66612

Learn more about the opioid crisis and engage in this proactive effort to build a collaborative response in Kansas by addressing the issue through multiple specialties such as prescribing, prevention, treatment, recovery, and intervention.


The Agency for Healthcare Research and Quality (AHRQ) has recently released a new practice facilitation guide for primary care.  Developing and Running a Primary Care Practice Facilitation Program: A How-To Guide was developed by AHRQ to support organizations interested in starting a practice facilitation (or quality improvement) program for primary care transformation. The guide focuses on designing and administering facilitation programs, not the content of an actual facilitation intervention.


The Kansas State Loan Repayment Program (SLRP) application deadline is July 31. Please read the Overview and Application Guidance and Frequently Asked Questions documents in their entirety before submitting questions or an application to the SLRP. These documents explain in detail, the rights and commitments of health care professionals selected to participate in the SLRP. A complete understanding of the commitment to serve at an approved practice site and the financial, legal and other consequences of failing to perform that commitment are critical to successful completion of the mandatory service commitment associated with a SLRP contract.

For information about the Kansas State Loan Repayment Program: http://www.kdheks.gov/olrh/FundLoan.html

For information about the National Health Service Corps Loan Repayment Program: https://nhsc.hrsa.gov/

To check the HPSA score in your area: https://datawarehouse.hrsa.gov/tools/analyzers/hpsafind.aspx


Earn CME while you support the Kansas Academy of Family Physicians. A portion of the price of each AAFP self-study package you purchase will go directly to KAFP to help support local initiatives. Use AAFP self-study packages to enhance your expertise and expand your knowledge on common family medicine topics. Featuring recorded audio and video presentations from current AAFP live courses.

Here’s how:


The AAFP’s national public service announcement campaign (PSA) continues in August with a segment on shingles. Each PSA will educate the audience about an issue and urge them to visit familydoctor.org for more information. Please help us educate our patients by referring them to the familydoctor.org website.

The following familydoctor.org months and/or topics will be highlighted and the PSAs will be released the first day of the appropriate month:

  • May – Mental and Emotional Health (bullying; launched)
  • July – Back to School (flu and the importance of personal hygiene; launched)
  • Aug – Immunizations (shingles for adults starting at 50 years of age)
  • Sept – Sports/Exercise at Every Age (concussions)
  • Oct – Family Health and Safety (gun safety)
  • Nov – Addiction and Recovery (opioid abuse and safe pill storage)

Each PSA has an English and Spanish version as well as radio and television formats. The August PSA will be released August 1.


August is National Immunization Awareness Month (NIAM). The Health is Primary campaign (www.healthisprimary.org) is participating in NIAM, and will focus on emphasizing the importance of immunizations across the lifespan – for babies, children, teens and adults – in preventing diseases and protecting public health. The August toolkit (www.healthisprimary.org) is available. Help spread the word on social media and use hashtags: #MakeHealthPrimary #ImmunizationsarePrimary #NIAM18



Join Substance Abuse and Mental Health Services Administration (SAMHSA) and the National Action Alliance for Suicide Prevention for a webinar on Wednesday, July 25 from noon to 1:30 p.m. to learn about developing and delivering effective suicide prevention messaging, in advance of National Suicide Prevention Week in September. The webinar presenters will highlight the Action Alliance’s Framework for Successful Messaging, an online, research-based resource that offers guidance on developing suicide prevention messaging.


There is still time to enroll in PRIME Registry and simplify your MIPS reporting for 2018. The PRIME Registry Manual MIPS Reporting tool is also available now—no EHR required. Enroll by clicking here.


Tuesday, July 17 is the deadline to register to vote in the August 7 primary. If you are not already registered, you can register to vote onlineby fax, or in person at your Kansas county election office.  We encourage you to consider candidates who support our Legislative Priorities.  In addition, Representative John Eplee, MD, FAAFP urges members to ask these two questions of primary candidates:

  • Do you support science behind vaccines?
  • Do you support legislation that would increase vaccination rates in Kansas?

Read instructions for registering to vote.

IAC Express

The American Journal of Preventive Medicine published a study by Sylvia Becker-Dreps et al. titled Effectiveness of Prenatal Tetanus, Diphtheria, Acellular Pertussis Vaccination in the Prevention of Infant Pertussis in the U.S. The abstract is reprinted below.

It is recommended that all pregnant women in the U.S. receive tetanus, diphtheria, acellular pertussis (Tdap) immunization to prevent infant pertussis. This study’s objective was to examine the clinical effectiveness of prenatal Tdap, and whether effectiveness varies by gestational age at immunization.

A nationwide cohort study of pregnant women with deliveries in 2010–2014 and their infants was performed. Commercial insurance claims data were analyzed in 2016–2017 to identify Tdap receipt by the pregnant women, and hospitalizations and outpatient visits for pertussis in their infants until the infants reached 18 months of age. Pertussis occurrence was compared between infants of mothers who received prenatal Tdap (overall and stratified by gestational age at administration) and infants of unvaccinated mothers.

There were 675,167 mother–infant pairs in the cohort. Among infants whose mothers received prenatal Tdap, the rate of pertussis was 43 percent lower (hazard ratio=0.57, 95% CI=0.35, 0.92) than infants whose mothers did not receive prenatal or postpartum Tdap; this reduction was consistent across pertussis definitions (hazard ratio for inpatient-only pertussis=0.32, 95% CI=0.11, 0.91). Pertussis rates were also lower for infants whose mothers received Tdap during the third trimester. Infants whose mothers received Tdap at <27 weeks of gestation did not experience reductions in pertussis rates (hazard ratio for pertussis=1.10, 95% CI=0.54, 2.25).

Infants of mothers who received prenatal Tdap experienced half the rate of pertussis as compared with infants of unimmunized mothers. These results do not provide evidence to support changing the currently recommended timing of Tdap administration in pregnancy.

Access the complete article:  Effectiveness of Prenatal Tetanus, Diphtheria, Acellular Pertussis Vaccination in the Prevention of Infant Pertussis in the U.S.